{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:59:15Z","timestamp":1767085155919},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.urology.2009.12.036","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T13:28:00Z","timestamp":1269955680000},"page":"919-922","source":"Crossref","is-referenced-by-count":11,"title":["Detection Rates of Nonpalpable Prostate Cancer in Korean Men With Prostate-specific Antigen Levels Between 2.5 and 4.0 ng\/mL"],"prefix":"10.1016","volume":"76","author":[{"given":"Hong Seok","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Soo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Duck","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wansuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Hyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byong Chang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Il","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2009.12.036_bib1","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/1097-0142(19941215)74:12<3146::AID-CNCR2820741214>3.0.CO;2-Z","article-title":"Cost-effective prostate cancer detection","volume":"74","author":"Littrup","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2009.12.036_bib2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1997.03540420048028","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/mL and benign prostate examination","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2009.12.036_bib3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0022-5347(05)67809-3","article-title":"Prostate cancer detection at low prostate specific antigen","volume":"163","author":"Schroder","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.036_bib4","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0022-5347(01)62395-4","article-title":"Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men","volume":"160","author":"Smith","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.036_bib5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0090-4295(00)00830-X","article-title":"Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng\/mL","volume":"56","author":"Babaian","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.036_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.urology.2003.11.025","article-title":"Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng\/mL equivalent to that in men with 4.1 to 10.0 ng\/mL in a Japanese population","volume":"63","author":"Kobayashi","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.036_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2006.01.067","article-title":"T1c prostate cancer detection rate and pathologic characteristics: comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng\/mL and 4.1 to 10.0 ng\/mL in Korean population","volume":"68","author":"Park","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.036_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.ju.0000074747.72993.cb","article-title":"Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density","volume":"170","author":"Allan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.036_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pros.20017","article-title":"Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial","volume":"59","author":"Labrie","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2009.12.036_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000092583","article-title":"Should men with serum prostate-specific antigen < or = 4 ng\/ml and normal digital rectal examination undergo a prostate biopsy?","volume":"70","author":"Pepe","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.urology.2009.12.036_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-4295(02)01875-7","article-title":"Prostate-specific antigen cutoff of 2.6 ng\/mL for prostate cancer screening is associated with favorable pathologic tumor features","volume":"60","author":"Krumholtz","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.036_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2009.12.036_bib13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.164.11.1227","article-title":"Identification of clinically significant prostate cancer by prostate-specific antigen screening","volume":"164","author":"Smith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urology.2009.12.036_bib14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/cncr.20126","article-title":"Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma","volume":"100","author":"Hugosson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2009.12.036_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1464-410X.2003.04657.x","article-title":"Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of <4.0 ng\/mL","volume":"93","author":"Sokoloff","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.036_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1464-410X.2003.04361.x","article-title":"A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates","volume":"92","author":"Foley","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.036_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0302-2838(03)00139-8","article-title":"Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction","volume":"43","author":"Augustin","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.036_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-5347(01)66317-1","article-title":"Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis","volume":"155","author":"Lerner","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.036_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0022-5347(05)66086-7","article-title":"Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer","volume":"166","author":"Noguchi","year":"2001","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T01:55:54Z","timestamp":1544579754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429510000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0090429510000026"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2009.12.036","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}